# Antimicrobial Treatment in Patients With Ventilator-associated Tracheobronchitis

> **NCT03012360** · PHASE4 · TERMINATED · sponsor: **University Hospital, Lille** · enrollment: 103 (actual)

## Conditions studied

- Mechanical Ventilation Complication
- Critical Illness

## Interventions

- **DRUG:** ceftriaxone
- **DRUG:** ciprofloxacin
- **DRUG:** imipenem
- **DRUG:** linezolid
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03012360
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-02-08
- **Primary completion:** 2024-07-07
- **Final completion:** 2024-07-07
- **Target enrollment:** 103 (ACTUAL)
- **Why stopped:** lack of inclusion pandemic, investigator reluctance, lower than expected incidence of infection
- **Last updated:** 2025-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03012360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03012360, "Antimicrobial Treatment in Patients With Ventilator-associated Tracheobronchitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03012360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*